Cytochrome P450 genes expression in human prostate cancer
Open Access
- 9 January 2024
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 38, 101049
Abstract
No abstract availableKeywords
Funding Information
- Simons Foundation (1030279)
This publication has 39 references indexed in Scilit:
- Vitamin D metabolism and action in the prostate: Implications for health and diseaseMolecular and Cellular Endocrinology, 2011
- Vitamin D Receptor Protein Expression in Tumor Tissue and Prostate Cancer ProgressionJournal of Clinical Oncology, 2011
- Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate CancerThe American Journal of Pathology, 2011
- Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonistsCancer Science, 2010
- Smoking as a Risk Factor for Prostate Cancer: A Meta-Analysis of 24 Prospective Cohort StudiesAmerican Journal of Public Health, 2010
- CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growthProceedings of the National Academy of Sciences, 2009
- Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancerEndocrine-Related Cancer, 2007
- Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug developmentBioorganic & Medicinal Chemistry, 2007
- The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesisNature Reviews Cancer, 2006
- Tobacco smoke induces CYP1B1 in the aerodigestive tractCarcinogenesis, 2004